Mao Y - Search Results

1

Bioprinting of in vitro tumor models for personalized cancer treatment: a review.

Mao S, Pang Y, Liu T, Shao Y, He J, Yang H, Mao Y, Sun W. Mao S, et al. Among authors: mao y. Biofabrication. 2020 Jul 9;12(4):042001. doi: 10.1088/1758-5090/ab97c0. Biofabrication. 2020. PMID: 32470967 Review.

2

Golgi protein 73, not Glypican-3, may be a tumor marker complementary to α-Fetoprotein for hepatocellular carcinoma diagnosis.

Wang Y, Yang H, Xu H, Lu X, Sang X, Zhong S, Huang J, Mao Y. Wang Y, et al. Among authors: mao y. J Gastroenterol Hepatol. 2014 Mar;29(3):597-602. doi: 10.1111/jgh.12461. J Gastroenterol Hepatol. 2014. PMID: 24236824

3

Noninvasive detection of tumor-associated mutations from circulating cell-free DNA in hepatocellular carcinoma patients by targeted deep sequencing.

Liao W, Yang H, Xu H, Wang Y, Ge P, Ren J, Xu W, Lu X, Sang X, Zhong S, Zhang H, Mao Y. Liao W, et al. Among authors: mao y. Oncotarget. 2016 Jun 28;7(26):40481-40490. doi: 10.18632/oncotarget.9629. Oncotarget. 2016. PMID: 27248174 Free PMC article.

4

Three-dimensional printing: review of application in medicine and hepatic surgery.

Yao R, Xu G, Mao SS, Yang HY, Sang XT, Sun W, Mao YL. Yao R, et al. Cancer Biol Med. 2016 Dec;13(4):443-451. doi: 10.20892/j.issn.2095-3941.2016.0075. Cancer Biol Med. 2016. PMID: 28154775 Free PMC article.

5

Management of intrahepatic recurrence after resection for hepatocellular carcinoma exceeding the barcelona clinic liver cancer criteria.

Xu W, Guo R, Xu G, Sun L, Hu D, Xu H, Yang H, Sang X, Lu X, Mao Y. Xu W, et al. Among authors: mao y. Oncotarget. 2017 Nov 30;8(66):110406-110414. doi: 10.18632/oncotarget.22779. eCollection 2017 Dec 15. Oncotarget. 2017. PMID: 29299157 Free PMC article.

6

Combination of tumor-associated regulatory T cell deletion and PD-1/PD-L1 blockade: A promising immunotherapy for hepatocellular carcinoma?

Yang HY, Sun LJ, Mao YL. Yang HY, et al. Hepatobiliary Pancreat Dis Int. 2018 Apr;17(2):93-94. doi: 10.1016/j.hbpd.2018.03.001. Epub 2018 Mar 8. Hepatobiliary Pancreat Dis Int. 2018. PMID: 29576280 No abstract available.

7

Patient-derived organoids: a promising model for personalized cancer treatment.

Yang H, Sun L, Liu M, Mao Y. Yang H, et al. Among authors: mao y. Gastroenterol Rep (Oxf). 2018 Nov;6(4):243-245. doi: 10.1093/gastro/goy040. Epub 2018 Oct 9. Gastroenterol Rep (Oxf). 2018. PMID: 30430011 Free PMC article. No abstract available.

8

The role of exosomes in tumor immunity.

Yang H, Sun L, Mao Y. Yang H, et al. Among authors: mao y. Ann Transl Med. 2018 Dec;6(Suppl 2):S116. doi: 10.21037/atm.2018.12.03. Ann Transl Med. 2018. PMID: 30740437 Free PMC article. No abstract available.

9

Correlation Between PD-L2 Expression and Clinical Outcome in Solid Cancer Patients: A Meta-Analysis.

Yang H, Zhou X, Sun L, Mao Y. Yang H, et al. Among authors: mao y. Front Oncol. 2019 Feb 13;9:47. doi: 10.3389/fonc.2019.00047. eCollection 2019. Front Oncol. 2019. PMID: 30891423 Free PMC article.

10

Extracellular vesicles in hepatocellular cancer and cholangiocarcinoma.

Xie F, Feng S, Yang H, Mao Y. Xie F, et al. Among authors: mao y. Ann Transl Med. 2019 Mar;7(5):86. doi: 10.21037/atm.2019.01.12. Ann Transl Med. 2019. PMID: 31019936 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10,631 results

Search Page

Filters